Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Physiological Reports|March 16, 2017
β-GPA treatment leads to elevated basal metabolic rate and enhanced hypoxic exercise tolerance in miceTrenton T Ross, Jeffrey D Overton, Katelyn F Houmard, et al.Metabolism: Clinical and Experimental|May 28, 2019
The combination of exercise training and sodium-glucose cotransporter-2 inhibition improves glucose tolerance and exercise capacity in a rodent model of type 2 diabetesMelissa A Linden, Trenton T Ross, David A Beebe, et al.Journal of Lipid Research|August 25, 2024
Murine HSD17β13 does not control liver steatosis and modestly impacts fibrosis in a sex- and diet-specific mannerJustin D Crane, Ornella Barrandon, Bryan Faherty, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|November 28, 2020
Inhibition of Acetyl-CoA Carboxylase Causes Malformations in Rats and Rabbits: Comparison of Mammalian Findings and Alternative AssaysNatasha R Catlin, Christopher J Bowman, Sarah N Campion, et al.Cellular and Molecular Gastroenterology and Hepatology|October 16, 2023
GPAT1 Deficiency in Mice Modulates NASH Progression in a Model-Dependent MannerKathleen R Smith, Wenshan Wang, Melissa R Miller, et al.Cellular and Molecular Gastroenterology and Hepatology|June 12, 2020
Acetyl-CoA Carboxylase Inhibition Improves Multiple Dimensions of NASH Pathogenesis in Model SystemsTrenton T Ross, Collin Crowley, Kenneth L Kelly, et al.The Journal of Clinical Investigation|March 10, 2026
Impaired glycosylation promotes rapid transition to hepatocellular carcinoma in model of diet induced steatotic liver diseaseAbhishek K Singh, Balkrishna Chaube, Kathryn M Citrin, et al.Nature Medicine|October 12, 2021
ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trialsRoberto A Calle, Neeta B Amin, Santos Carvajal-Gonzalez, et al.Plos One|May 27, 2014
The hepatoselective glucokinase activator PF-04991532 ameliorates hyperglycemia without causing hepatic steatosis in diabetic ratsDerek M Erion, Amanda Lapworth, Paul A Amor, et al.Nature Metabolism|September 15, 2020
De novo lipogenesis is essential for platelet production in humansKenneth L Kelly, William J Reagan, Gabriele E Sonnenberg, et al.Pageof 2